According to Renovaro Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โฌ39.57 Million, an increase over its 2022 earnings that were of -โฌ0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.